Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

Study Examines How Speech Patterns Change With Age

At the American Academy of Neurology annual meeting, researchers presented a study involving cognitively normal individuals that examined speech behavior in connected speech tasks to

May 4, 2024

New study pinpoints key markers for Long COVID diagnosis

Study identifies elevated serologic responses and memory CD8+ T cell clonal expansion as key markers of Long COVID, offering insights into its pathology and potential

February 18, 2024

Alnylam reveals positive Phase III results for rare heart disease drug vutrisiran – Pharmaceutical Technology

RNAi therapeutic, vutrisiran is FDA approved for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTR) in adults and is sold under the brand name

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.